| Abstract: | Bachground: Bone metastasis is very frequent in prostate cancer. It is a turning point that marks the severity of the disease. Before metastasis become symptomatic, treatment preventing bone events should be indicated. Aim: To evaluate the role of bisphosphonate in the treatment of bone metastases from prostate cancer. Methods: A review of literature Results: Bisphosphonates play a very important role to prevent bone mass loss and to reduce bone complication events. Conclusion: Bisphosphonates are recommended as preventive treatment at the time of diagnosis of bone metastatic prostate cancer. |
